Healcome Lidocaine Numbing Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Healcome Lidocaine Numbing Cream
Generic name
LIDOCAINE
Manufacturer
YITONGBADA (SHENZHEN) INTERNATIONAL TRADE CO., LTD
Product type
HUMAN OTC DRUG
SPL set ID
9b4eac02-1b1f-4630-92b4-b1d8c21abab5
SPL ID
52f5bc39-cdab-ab37-e063-6394a90ab9da
Version
2
Effective date
2026-05-29
Source export date
2026-11-13
Source partition
2
Source file
https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/3b4204ed830f35b16ab24b2123672d7d93066eb0fd8af1cf09b223d0e4568221/drug-label-0002-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 15:30:40
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only When using this product Avoid contact with eyes. Do not exceed the recommended daily dosage unless directed by a doctor. Do not put this product into the rectum by using fingers or any mechanical device or applicator. Stop use and ask a doctor if Condition worsens or does not improve within 7 days. An allergic reaction occurs to ingredients in this product. Redness, irritation, swelling, pain, or other symptoms develop or increase. Symptoms clear up and occur again within a few days. Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center right away. If pregnant or breastfeeding , ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.